Glaukos Corp.

GKOS ·Healthcare, Medical Devices, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013
Operating Activities
Net Income $-92.0K $4.5M $-37.2M $-12.1M $-12.6M
Depreciation & Amortization $5.5M $4.7M $4.3M $4.2M $1.2M
Depreciation
Amortization $3.7M $3.5M $3.5M $500.0K
Stock-Based Compensation $17.6M $8.8M $7.9M $1.5M $1.3M
Net Cash from Operating Activities $26.1M $12.3M $-2.2M $-7.1M $-13.3M
Investing Activities
Capital Expenditures $6.3M $6.3M $877.0K $868.0K $852.0K
Business Acquisitions
Net Cash from Investing Activities $-12.4M $-26.1M $-85.6M
Financing Activities
Dividends Paid
Stock Repurchases $132.0K
Net Cash from Financing Activities $4.7M $-1.6M $107.1M
Net Change in Cash $18.0M $-15.1M $19.3M $-4.4M $5.0M
Free Cash Flow $19.8M $6.0M $-3.1M $-8.0M $-14.2M
← Newer Page 2 of 2 Older →